Jazz Pharmaceuticals plc — Director's Dealing 2015

Jul 8, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-07-06

Reporting Person: ENRIGHT PATRICK G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-06	Ordinary Shares	S	1078	$175.8073	Disposed	293029	Indirect
2015-07-06	Ordinary Shares	S	5196	$176.8559	Disposed	287833	Indirect
2015-07-06	Ordinary Shares	S	2986	$177.7383	Disposed	284847	Indirect
2015-07-06	Ordinary Shares	S	543	$178.5941	Disposed	284304	Indirect
2015-07-06	Ordinary Shares	S	22	$175.8073	Disposed	5871	Indirect
2015-07-06	Ordinary Shares	S	105	$176.8576	Disposed	5766	Indirect
2015-07-06	Ordinary Shares	S	60	$177.742	Disposed	5706	Indirect
2015-07-06	Ordinary Shares	S	10	$178.591	Disposed	5696	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	1650	Direct

Footnotes

F1: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $175.27 to $176.26. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F2: The Reporting Person is a managing member of Longitude Capital Partners, LLC, the general partner of each of Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. The Reporting Person disclaims beneficial ownership of the securities of the Issuer held by Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. except to the extent of his pecuniary interest therein.

F3: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $176.39 to $177.37. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F4: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $177.39 to $178.15. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F5: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $178.49 to $178.92. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F6: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $175.27 to $176.26. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F7: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $176.39 to $177.37. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F8: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $177.39 to $178.15. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F9: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $178.49 to $178.76. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.